French Multidisciplinary Consortium Arpege Awarded Public Funding Of Close To €9 Million To Fight Antibiotic Resistance
French Multidisciplinary Consortium Arpege Awarded Public Funding Of Close To €9 Million To Fight Antibiotic Resistance
01/06/22, 1:00 AM
Industry
financial services
The ARPEGE[1] project aims to develop a set of solutions to strengthen the ability of healthcare institutions to fight antibiotic resistance. The consortium, led by Antabio, has been awarded close to €9 million in public funding under the "PSPC" call for projects conducted on behalf of the French government by Bpifrance.
Company Info
Additional Info
According to Jean Tirole, Honorary President of TSE and winner of the 2014 Nobel Prize in Economics: "Antibiotic resistance is a major problem for society, and my colleagues and I are excited to place economic science in support of ARPEGE in order to offer long-term solutions that will deliver improved global health."Media Contacts:ARPEGE Marc Lemonnier [email protected] Sylvie Berrebi [email protected] Bpifrance Sophie Santandrea Tel: +33 (0)1 45 65 51 62 [email protected] General Secretariat for Investment Tel: +33 (0)1 42 75 64 58 [email protected] About AntabioAntabio is a private biopharmaceutical company specialized in the development of new therapies for severe and life-threatening multidrug-resistant infections.